Nanotechnology-Based Stem Cell Therapy: Current Status and Perspectives

Author:

Samuel Ponpandian,Sundarraj Shenbagamoorthy,Sudarmani D.N.P.

Abstract

The nanoparticles or nanobots are equivalent to the size of biological molecules of the human body and this is claimed to be the massive advantage of nanotechnology. Currently, top-down and bottom-up fabrication methods are being adopted to synthesize nanomaterials. Hence, the products developed from nanotechnology can be used for assessment of several biological parameters under in vitro and in vivo conditions. Effective production of nanoparticles, accompanied by the advent of novel characterization studies, enables us to manipulate the arrangement of atoms distributed on the surface of the nanomaterials to make it functionally more effective than before. In addition to the support imparted by nanotechnology, it also plays a primary role in the field of diagnostics. Another important outcome of nanotechnology is nanomedicine, which deals with the site-specific delivery of drugs with the aid of fabricated nanosystems. The advent of technology in recent years has enabled researchers to build novel forms of drug delivery systems like liposomes, dendrimers, nanoparticles and nanocrystals, which in turn ensure the précised delivery of drugs to suitable targets. Several need-based and value-added applications of nanotechnology are enlisted in the chapter.

Publisher

IntechOpen

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Frontiers of stem cell engineering for nanotechnology-mediated drug delivery systems;ADMET and DMPK;2024-02-14

2. Sustainable Use of Nanotechnology in Biomedical Sciences;Advances in Medical Diagnosis, Treatment, and Care;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3